Difference between revisions of "Team:Lethbridge/HP/Gold"

Line 196: Line 196:
 
</div>
 
</div>
  
<div class="row">
+
<div class="row" id="ridealong">
 
   <div class="col s12 red darken-2">
 
   <div class="col s12 red darken-2">
 
     <div class="container">
 
     <div class="container">
Line 209: Line 209:
 
</div>
 
</div>
  
<div class="row">
+
<div class="row" id="protocol">
 
   <div class="col s12 red darken-1">
 
   <div class="col s12 red darken-1">
 
     <div class="container">
 
     <div class="container">
Line 222: Line 222:
 
</div>
 
</div>
  
<div class="row">
+
<div class="row" id="sampling">
 
   <div class="col s12 red darken-1">
 
   <div class="col s12 red darken-1">
 
     <div class="container">
 
     <div class="container">

Revision as of 21:21, 16 October 2016

Lethbridge iGEM 2016

Human Practices (Gold)

Ridealongs, Protocol Design, Ambulance Sampling

Ridealongs

The prevalence of virulent and multiple antibiotic resistant pathogens in healthcare facilities has resulted in ongoing reassessment of best practices to prevent their transmission. However, whether pathogen reservoirs exist in emergency medical services (EMS) vehicles, remains largely unknown. Our iGEM team developed a custom bacterial two hybrid system to select single-domain antibodies (nanobodies) that recognize human pathogens. Informed by our Nanopore next generation sequencing of DNA samples from ambulance vehicles, antibodies targeting important pathogens were then used to develop a rapid and low cost ELISA-based testing kit that may be employed on-site by EMS workers. Our project provides a framework for rapid detection of emergent pathogens and a practical and rapid solution for monitoring their presence in and outside of the healthcare system.

Protocol Design

The prevalence of virulent and multiple antibiotic resistant pathogens in healthcare facilities has resulted in ongoing reassessment of best practices to prevent their transmission. However, whether pathogen reservoirs exist in emergency medical services (EMS) vehicles, remains largely unknown. Our iGEM team developed a custom bacterial two hybrid system to select single-domain antibodies (nanobodies) that recognize human pathogens. Informed by our Nanopore next generation sequencing of DNA samples from ambulance vehicles, antibodies targeting important pathogens were then used to develop a rapid and low cost ELISA-based testing kit that may be employed on-site by EMS workers. Our project provides a framework for rapid detection of emergent pathogens and a practical and rapid solution for monitoring their presence in and outside of the healthcare system.

Ambulance Sampling

The prevalence of virulent and multiple antibiotic resistant pathogens in healthcare facilities has resulted in ongoing reassessment of best practices to prevent their transmission. However, whether pathogen reservoirs exist in emergency medical services (EMS) vehicles, remains largely unknown. Our iGEM team developed a custom bacterial two hybrid system to select single-domain antibodies (nanobodies) that recognize human pathogens. Informed by our Nanopore next generation sequencing of DNA samples from ambulance vehicles, antibodies targeting important pathogens were then used to develop a rapid and low cost ELISA-based testing kit that may be employed on-site by EMS workers. Our project provides a framework for rapid detection of emergent pathogens and a practical and rapid solution for monitoring their presence in and outside of the healthcare system.